Great madamswer,
....and in the process of discussion, it's easy to see where there is skewed analysis.
All you do is talk about income. You don't give any kind of value to the technology being proven so far in clinical trials, nor of the advanced cardiac clinical trials, nor of it going to market in Japan earlier.
The analysts however have clearly valued these things. along with the JV with Teva and many other factors.
You refuse to agree that MSB is an emerging blue chip, but you act as if it already should be one.
- Forums
- ASX - By Stock
- One for flat earth simple believers
Great madamswer, ....and in the process of discussion, it's easy...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.644B |
Open | High | Low | Value | Volume |
$1.50 | $1.50 | $1.43 | $4.048M | 2.778M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 26808 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 16001 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 26808 | 1.440 |
2 | 28628 | 1.435 |
8 | 68533 | 1.430 |
5 | 155422 | 1.425 |
4 | 32112 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.445 | 16001 | 1 |
1.450 | 4515 | 1 |
1.455 | 6500 | 1 |
1.460 | 45215 | 3 |
1.465 | 36008 | 2 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online